PTOYSHES {07-09}
`Approved for use through 07/34/2012 OMB 0684-0031
`U.S. Patent and Trademark Office; U.S. OEPARTMENT OF COMMERCE
`Under the Paperwork ReductionAct of 1998, na persons are required te respond tea collection of information unless if displays a valid OMS contral number,
`
`STATEMENT UNDER 37 CFR 3.73(b}
`
`| Apglicant/Patent Owner, Apotex Technologies, inc.
`| Application No/Patent No: 10/311,814/7,046,328
`| Titled:
`
`USE FOR DEFERIPRONE
`
`
`. Fiediseua Date -Apa4, 2008/May28,2008
`
`
`
`
`
`
`
`
`
`
`
`| Apotex Technologies,Inc.
`a corporation
`
`in, universily, gavermment agency, atc,
`(Name of Assignes}
`
`states that itis:
`
`
`
`
`an assignee of less than the antire right, tile, and interest in
`
`iThe extant (by peresniags} of Hs ownership interest is : Soy or
`
`
`
`i| the assignee of an undivided Interest in ihe entirety of (a complete assignment from ane of the joint inventors was made}
`3.
`
`
`the patent agpliication/patent identified above, by virtue of either:
`
`
`
`A i| An assignment from the invenior(s} of the patent aoplication/patent identified above. Tha assignmant waa recorded in
`ihe United Sistes Patent and Trademark Office at Reel =, Frame
`_ oF for which a
`copy therefore is aitached.
`
`
`
`
`
`
`To: APOTEXINC.
`2. From: PIGA,ANTONIO,DR.SPINO.MICHAEL,Di
`
`The dooument was recorded in the United States Patent and Trademark Office at
`Ree Uavdsd or for which a copy thereof is atlached.
`
`
`
`
`
`The document was recorded in ihe United States Patent and Trademark Office at
`awnene
`Reet CS8OTS
`, Frare O82e
`ceeeeteeccneesseneesenee
`
`
`
`
`
`[| As required by 37 GFR 3.73(6)( 11), the documentary evidence of the chain of title from the original ownerio ihe assigqnas was,
`or concurrently is being, submilted for recordation pursuant to 37 CFR 3.41.
`
`
`INOTE: A separate copy (Le., a true capy of the original assignment document(s} must be submitted to Assignment Division in
`accerdance with 37 CFR Part 3, to record the assignmentin the records of the USPTO. See MPEP 302.08]
`:
`
`The undarsigned évhogetitle Is supplied below) is authorized to act on behalf of the assignee.
`oS
`
`
`
`GSiobal Director, Portfolio Mbgg
`Title
`IAAPANISH AAAA
`
`This collection of informationis rea
`
`‘ad by 37 CFR 3.73(b). The information is required to obtain or reiain a benefit by ihe public which ig to fle fand by the USPTO to
`process) an application, Confide
`y is governed by 35 5.0. 122 and 37 CFR 4.41 and 1.14. This collection is estimated te take 12 minutes to complete, including
`
`
`gathering,
`preparing, anc subrnitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any camments on the amount of fime
`
`yourequire io complete this farm and/or suggestions for reducing this burden, should be gent to the Chiefinformation Officer, U.S. Patent and Trademark Office, U.S.
`Department of Commerce, P.0, Box 1480, Alaxandia, VA 22313-1450. DO NOT SENG FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner
`far Patents, P.O, Box 1486, Alexandria, YA 23343-1450.
`
`the assignee of the entire right, title, and interestin
`
`oR
`8. | A chain of title from the inventor(s}, of the patent application/patent identified above, io the current assignee as follows:
`1. Frost: APOTEX INC.
`To: APOTEXTECHNOLOGIES INC.
`The document was recorded in the United States Patent and Trademark Office at
`Reet 018628
`_,
`Frame 0603
`.
`or for which a copy thereofis atiached.
`
`Additional documents in the chain of litte ara lisiad on a supplemental sheates).
`
`To: APOTEX TECHNOLOGIES INC,
`
`or for which a capy thereof is atlachad.
`
`_
`
`
`
`i
`
`
`
`
`
`# you need assistance ia completing the form, call 1-800-710-9198 and select option 2.
`
`Apotex Tech.
`Ex. 2018
`
`Apotex Tech.
`Ex. 2018
`
`

`

`Electronic Patent Application Fee Transmittal
`
`Title of Invention:
`
`USE FOR DEFERIPRONE
`
`eine
`
`Extension-of-Time:
`
`Filing Fees for U.S. National Stage under 35 USC 371
`
`Description
`
`Fee Code
`
`Quantity
`
`Sub-Total in
`
`USD(S)
`
`Basic Filing:
`
`Miscellaneous-Filing:
`
`Patent-Appeals-and-Interference:
`
`Post-Allowance-and-Post-Issuance:
`
`

`

`Description
`
`Miscellaneous:
`
`Total in USD ($)
`
`Sub-Total in
`USD(S)
`
`Fee Code
`
`Quantity
`
`

`

`International Application Number:
`
`Confirmation Number:
`
`2281
`
`Title of Invention:
`
`USE FOR DEFERIPRONE
`
`Electronic AcknowledgementReceipt
`
`Application Number:
`
`10311814
`
`
`
`a
`
`Paymentinformation:
`
`The Director of the USPTO is hereby authorized to charge indicated fees and credit any overpaymentas follows:
`
`
`
`[Pevostacone——SSSCSCSC~*sdSCS
`
`

`

`File Listing:
`
`Pages
`Multi
`File Size(Bytes)/
`DocumentDescription
`Document
`
`
`
`Number Message Digest|Part/.zip|P (if appl.)
`
`1
`
`Statutory disclaimers per MPEP 1490
`
`Executed-1-321.pdf
`
`€24d83 10f9230c6c4292e563f94bc165a099}
`b291
`
`1
`
`Information:
`
`The page size in the PDF is too large. The pages should be 8.5 x 11 or A4.If this PDF is submitted, the pageswill be resized upon entry into the
`Image File Wrapper and mayaffect subsequent processing
`
`Information:
`
`3
`
`Assignee showing of ownership per 37
`CFR 3.73
`
`Executed-3-73bpdf
`
`a13420d5c7da61381b7285544a68eb048ay
`36763
`
`1
`
`The page size in the PDF is too large. The pages should be 8.5 x 11 or A4.If this PDF is submitted, the pageswill be resized upon entry into the
`Image File Wrapper and mayaffect subsequent processing
`
`Information:
`
`3
`
`Fee Worksheet (SB06)
`
`fee-info.pdf
`
`95203d0dd4b6920e72400106b27e0d7340|
`059cef
`
`2
`
`

`

`This AcknowledgementReceipt evidences receipt on the noted date by the USPTO ofthe indicated documents,
`characterized by the applicant, and including page counts, where applicable.It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`the application.
`
`New Applications Under 35 U.S.C. 111
`If a new application is being filed and the application includes the necessary componentsfora filing date (see 37 CFR
`1.53(b)-(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shownonthis
`AcknowledgementReceiptwill establish the filing date of the application.
`National Stage of an International Application under 35 U.S.C. 371
`If a timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903indicating acceptanceof the application as a
`national stage submission under35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`New International Application Filed with the USPTO as a Receiving Office
`If a new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105)will be issued in due course, subject to prescriptions concerning
`national security, and the date shownon this AcknowledgementReceiptwill establish the international filing date of
`
`